Monterde, Presevinda C.

HRN: 17-33-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2025
CEFTAZIDIME 1GM (VIAL)
11/19/2025
11/26/2025
IV
2g
Q8
Urosepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines